130 related articles for article (PubMed ID: 3481842)
1. Tachykinin antagonist I: Specific, competitive and tissue-selective neurokinin B antagonists on contractile activity in smooth muscles.
Hashimoto T; Uchida Y; Naminohira S; Sakai T
Jpn J Pharmacol; 1987 Dec; 45(4):570-3. PubMed ID: 3481842
[TBL] [Abstract][Full Text] [Related]
2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
[TBL] [Abstract][Full Text] [Related]
4. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
[TBL] [Abstract][Full Text] [Related]
5. The contractile activities of neurokinin A, B and related peptides on smooth muscles.
Osakada F; Kubo K; Goto K; Kanazawa I; Munekata E
Eur J Pharmacol; 1986 Jan; 120(2):201-8. PubMed ID: 2419146
[TBL] [Abstract][Full Text] [Related]
6. Tachykinin-induced contractions in the circular muscle of guinea pig ileum.
Suzuki N; Mizuno K; Gomi Y
Jpn J Pharmacol; 1994 Jul; 65(3):233-40. PubMed ID: 7528285
[TBL] [Abstract][Full Text] [Related]
7. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
Hall JM; Flowers JM; Morton IK
Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
[TBL] [Abstract][Full Text] [Related]
8. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
Munekata E; Kubo K; Tanaka H; Osakada F
Peptides; 1987; 8(1):169-73. PubMed ID: 2437548
[TBL] [Abstract][Full Text] [Related]
10. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
11. Two NK-3 receptor subtypes: demonstration by biological and binding assays.
Nguyen QT; Jukic D; Chrétien L; Gobeil F; Boussougou M; Regoli D
Neuropeptides; 1994 Sep; 27(3):157-61. PubMed ID: 7529376
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro actions of mammalian tachykinins.
Holzer-Petsche U; Schimek E; Amann R; Lembeck F
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):130-5. PubMed ID: 2413373
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of (+/-) CP 96,345 and L-668,169 on neurokinin receptor mediated responses in rat and guinea-pig isolated tissues.
Razzaque Z; Longmore J
Neuropeptides; 1993 Sep; 25(3):169-74. PubMed ID: 7504215
[TBL] [Abstract][Full Text] [Related]
14. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of novel mammalian tachykinins, neurokinin alpha and neurokinin beta.
Kimura S; Goto K; Ogawa T; Sugita Y; Kanazawa I
Neurosci Res; 1984 Dec; 2(1-2):97-104. PubMed ID: 6085651
[TBL] [Abstract][Full Text] [Related]
16. Subtypes and excitation-contraction coupling mechanisms for neurokinin receptors in smooth muscle of the guinea-pig Taenia caeci.
Hall JM; Morton IK
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):225-34. PubMed ID: 1719434
[TBL] [Abstract][Full Text] [Related]
17. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
Burcher E; Buck SH; Lovenberg W; O'Donohue TL
J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
Guard S; Watson SP; Maggio JE; Too HP; Watling KJ
Br J Pharmacol; 1990 Apr; 99(4):767-73. PubMed ID: 1694464
[TBL] [Abstract][Full Text] [Related]
19. The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B.
Mastrangelo D; Mathison R; Huggel HJ; Dion S; D'Orléans-Juste P; Rhaleb NE; Drapeau G; Rovero P; Regoli D
Eur J Pharmacol; 1987 Feb; 134(3):321-6. PubMed ID: 3471518
[TBL] [Abstract][Full Text] [Related]
20. Binding sites for [125I]-Bolton-Hunter scyliorhinin II in guinea-pig ileum: a radioligand binding, functional and autoradiographic study.
Mussap CJ; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):301-9. PubMed ID: 7824047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
